Project Number GC-2012639 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2015 View Full Project Details for Glutamatergic Dysfunction in Cognitive Aging: Riluzole in Mild Cognitive Impairment (follow-on funding) Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator Pereira, Ana Principal Investigator First Name Ana Principal Investigator Last Name Pereira Awardee Organization The Rockefeller University Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $50,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
